Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil

The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used. In this case report are described two cases of severe pemphigus vulgaris re...

Full description

Bibliographic Details
Main Authors: Stephanie Del Rio Navarrete Biot, Joanna Pimenta de Araujo Franco, Ricardo Barbosa Lima, Henrique Novo Costa Pereira, Luiz Paulo José Marques, Carlos José Martins
Format: Article
Language:English
Published: Sociedade Brasileira de Dermatologia 2014-12-01
Series:Anais Brasileiros de Dermatologia
Subjects:
Antibodies, monoclonal
Immunosuppressive agents
Pemphigus
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962014000600980&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962014000600980&tlng=en

Similar Items